Pila Pharma AB (publ) (PILA.ST)

SEK 3.87

(5.16%)

Eps Summary of Pila Pharma AB (publ)

  • Pila Pharma AB (publ)'s latest annual eps in 2023 was -0.47 SEK , up 81.85% from previous year.
  • Pila Pharma AB (publ)'s latest quarterly eps in 2024 Q1 was -0.09 SEK , down -39.22% from previous quarter.
  • Pila Pharma AB (publ) reported an annual eps of -2.59 SEK in 2022, down -37.77% from previous year.
  • Pila Pharma AB (publ) reported an annual eps of -1.88 SEK in 2021, down -180.6% from previous year.
  • Pila Pharma AB (publ) reported a quarterly eps of -0.09 SEK for 2024 Q1, down -39.22% from previous quarter.
  • Pila Pharma AB (publ) reported a quarterly eps of -0.17 SEK for 2023 Q2, up 50.0% from previous quarter.

Annual Eps Chart of Pila Pharma AB (publ) (2023 - 2015)

Historical Annual Eps of Pila Pharma AB (publ) (2023 - 2015)

Year Eps Eps Growth
2023 -0.47 SEK 81.85%
2022 -2.59 SEK -37.77%
2021 -1.88 SEK -180.6%
2020 -0.67 SEK 16.25%
2019 -0.80 SEK -122.22%
2018 -0.36 SEK -18.81%
2017 -0.30 SEK -218.95%
2016 -0.10 SEK -66.67%
2015 -0.06 SEK 0.0%

Peer Eps Comparison of Pila Pharma AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK 14.545%
Ziccum AB (publ) -1.54 SEK 69.481%
Modus Therapeutics Holding AB (publ) -1.01 SEK 53.465%
BioArctic AB (publ) 2.60 SEK 118.077%
Sprint Bioscience AB (publ) -0.01 SEK -7360.317%
Mendus AB (publ) -4.40 SEK 89.318%
Genovis AB (publ.) 0.94 SEK 150.0%
Intervacc AB (publ) -1.69 SEK 72.189%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -113.636%
Active Biotech AB (publ) -0.17 SEK -176.471%
Magle Chemoswed Holding AB (publ) 1.13 SEK 141.593%
Bio-Works Technologies AB (publ) -1.57 SEK 70.064%
Aptahem AB (publ) -0.05 SEK -873.085%
Vicore Pharma Holding AB (publ) -3.22 SEK 85.404%
Kancera AB (publ) -0.80 SEK 41.25%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 95.276%
Fluicell AB (publ) -0.24 SEK -95.833%
Saniona AB (publ) -1.29 SEK 63.566%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -147.368%
Biovica International AB (publ) -2.14 SEK 78.037%
Spago Nanomedical AB (publ) -0.43 SEK -9.302%
AcouSort AB (publ) -1.29 SEK 63.566%
Xintela AB (publ) -0.13 SEK -261.538%
Abliva AB (publ) -0.09 SEK -419.912%
Egetis Therapeutics AB (publ) -1.27 SEK 62.992%
Karolinska Development AB (publ) 0.02 SEK 2450.0%
OncoZenge AB (publ) -1.36 SEK 65.441%
Amniotics AB (publ) -0.01 SEK -4172.727%
2cureX AB (publ) -1.85 SEK 74.595%
CombiGene AB (publ) -1.80 SEK 73.889%
Asarina Pharma AB (publ) -0.57 SEK 17.544%
Calliditas Therapeutics AB (publ) -8.69 SEK 94.591%
Camurus AB (publ) 7.78 SEK 106.041%
Corline Biomedical AB -0.08 SEK -458.195%
IRLAB Therapeutics AB (publ) -3.43 SEK 86.297%
Isofol Medical AB (publ) -0.23 SEK -104.348%
I-Tech AB 1.70 SEK 127.647%
Hansa Biopharma AB (publ) -15.83 SEK 97.031%
Cyxone AB (publ) -0.22 SEK -113.636%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 76.263%
Biosergen AB -0.60 SEK 21.667%
Cantargia AB (publ) -1.65 SEK 71.515%
NextCell Pharma AB -1.03 SEK 54.369%
Xspray Pharma AB (publ) -6.76 SEK 93.047%
Elicera Therapeutics AB (publ) -0.83 SEK 43.373%
Nanologica AB (publ) -2.05 SEK 77.073%
SynAct Pharma AB -6.64 SEK 92.922%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -80.769%
Stayble Therapeutics AB (publ) -0.92 SEK 48.913%
LIDDS AB (publ) -0.63 SEK 25.397%
Lipum AB (publ) -4.45 SEK 89.438%
BioInvent International AB (publ) -5.02 SEK 90.637%
Alzinova AB (publ) -0.41 SEK -14.634%
Oncopeptides AB (publ) -1.96 SEK 76.02%
Guard Therapeutics International AB (publ) -11.26 SEK 95.826%
Scandinavian ChemoTech AB (publ) -1.13 SEK 58.407%
Simris Alg AB (publ) -0.16 SEK -193.75%
Diamyd Medical AB (publ) -1.60 SEK 70.625%
Xbrane Biopharma AB (publ) -1.27 SEK 62.992%
Ascelia Pharma AB (publ) -3.24 SEK 85.494%
Diagonal Bio AB (publ) -0.32 SEK -46.875%